Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02774005 · ClinicalTrials.gov registry record · Phase 4
Study to Assess the Efficacy and Safety of Raxone in LHON Patients
A Phase 4 study, sponsored by Santhera Pharmaceuticals.
- Completed
- Registry status
- Phase 4
- Development phase
- 199
- Enrollment target
NCT02774005 is a Phase 4 study that has completed, run by Santhera Pharmaceuticals. The registered enrollment target is 199 participants.
The verdict
NCT02774005, a Phase 4 study, has completed, sponsored by Santhera Pharmaceuticals.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 199 participants
- Enrollment target
Study Summary
LEROS is an open-label interventional Phase IV study, designed to further assess the efficacy and safety of Raxone® in the long-term treatment of LHON patients.
Interventions
- DRUG Idebenone
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 199 participants |
| Start Date | 2016-05 |
| Est. Completion | 2021-03-29 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02774005
The ClinicalTrials.gov registry entry for NCT02774005 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 199 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Santhera Pharmaceuticals, which has 7 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Idebenone is the first listed.
NCT02774005 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02774005 about?
NCT02774005 is a clinical study titled "Study to Assess the Efficacy and Safety of Raxone in LHON Patients". LEROS is an open-label interventional Phase IV study, designed to further assess the efficacy and safety of Raxone® in the long-term treatment of LHON patients.
What is the current status of trial NCT02774005?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 199 participants. The study started on 2016-05. Estimated completion is 2021-03-29.
What interventions are being tested in trial NCT02774005?
The interventions under investigation include: Idebenone (DRUG).
Who is sponsoring clinical trial NCT02774005?
This trial is sponsored by Santhera Pharmaceuticals, which has 7 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.